1. Home
  2. ETON vs GNSS Comparison

ETON vs GNSS Comparison

Compare ETON & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.83

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$2.22

Market Cap

98.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
GNSS
Founded
2017
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
498.8M
98.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
GNSS
Price
$16.83
$2.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$29.67
$5.25
AVG Volume (30 Days)
240.7K
154.2K
Earning Date
11-06-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,316,000.00
$40,757,000.00
Revenue This Year
$107.23
$83.82
Revenue Next Year
$29.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
102.77
69.76
52 Week Low
$11.09
$1.46
52 Week High
$23.00
$3.73

Technical Indicators

Market Signals
Indicator
ETON
GNSS
Relative Strength Index (RSI) 53.73 49.56
Support Level $16.27 $2.15
Resistance Level $16.95 $2.30
Average True Range (ATR) 0.64 0.12
MACD 0.16 0.00
Stochastic Oscillator 75.95 59.62

Price Performance

Historical Comparison
ETON
GNSS

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: